글로벌 돼지 백신 시장 – 2030년까지의 산업 동향 및 예측

돼지 백신 시장 분석 및 규모

전 세계적으로 돼지 질병 발생률이 증가하는 것은 시장 성장을 촉진하는 주요 요인 중 하나입니다. 미국에서 백신 개발의 진전은 살아있는 벡터 백신, 핵산 매개 백신, 비복제 재조합 항원 백신, 살아있는 유전자 삭제 백신의 개발을 포함합니다. 가금류 백신 시장에서 운영되는 여러 회사는 주로 자사의 입지를 강화하기 위한 새로운 기술 솔루션 개발에 집중했습니다.

Data Bridge Market Research는 2022년에 16억 달러였던 돼지 백신 시장이 2030년까지 24억 달러로 증가할 것으로 분석하고, 2023년에서 2030년까지의 예측 기간 동안 5.20%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

돼지 백신 시장 범위 및 세분화

Market Definition

The porcine vaccine is an administrative and clinical drug that helps improve swine health. These vaccines are known to protect from serious viruses, pathogens, and bacteria. Swine influenza, respiratory syndrome, diarrhea, and respiratory syndrome have been greatly minimized from spreading in an endemic manner because of these vaccines. It is widely used in several diseases, such as avian influenza and infectious bronchitis, requiring dosage form in liquid, freeze-dried, and duct.

Global Porcine Vaccines Market Dynamics

Drivers

• Increasing Research Activities Associated with Porcine vaccines

The increasing R&D activities by the major market players for developing novel porcine vaccines to treat diseases and increasing product approvals are anticipated to aid in the positive growth of the studied market during the forecast period. For instance, the Classical Swine Fever (CSF) vaccine was launched under the Raksha Class by Indian Immunologicals Limited (IIL) brand name in 2021. Therefore, increasing product launches expected market growth over the forecast period. This factor leads to the growth of the market.

• Increasing Healthcare Expenditure from Organizations

There have been rising healthcare expenditures that have led to market growth. For instance, in 2021, as per the Congress Budget Office report, the pharmaceutical industry spent USD 83 billion on research and development. These costs were paid for numerous activities, which include discovering and testing new drugs, developing incremental innovations such as product extensions, and conducting clinical trials for safety monitoring or marketing purposes. Thus, this factor help in the market growth.

Opportunities

• Increasing Awareness of Vaccination Services in Universities

Veterinary universities primarily deliver vaccination services to assist small-scale porcine farmers with disease control measures. For instance, the College of Veterinary Medicine at the University of Illinois created a website to offer information and resources to pork producers for their biosecurity program on farms. Also, training farm employees is creating a biosecurity plan that is necessary to prevent high-risk pathogens from entering and affecting swine farms. Thus, this factor boosts market growth.  

• Increasing Usage of Inactivated Vaccines

Recently, inactivated vaccines are in use, leading to market growth. This is due to its easy availability, low cost, and stability advantages over live-attenuated vaccines. They reduce the risk of virulence reversion after vaccination, as it helps prevent pathogens' replication process. Furthermore, it provides swine with better immunization with a rapid cell-mediated immune response. Thus, this factor serves as a major factor that increases market growth.

Restraints/Challenges

• Side-Effects of Porcine Vaccines

Numerous effects are associated with porcine vaccine products. Local effects such as discomfort and local swelling at the vaccination site, reduced appetite and activity, sneezing, mild fever, a snotty nose, and mild coughing. Thus, this factor impedes market growth.  

This porcine vaccines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the porcine vaccines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2022, Merck Animal Health received license approval in the U.S. from the Department of Agriculture (USDA) for its Circumvent CML vaccine. Merck passed a press release that claims Circumvent CML is the first-ready-to-use, single-dose vaccine which is effective against disease caused by Porcine Circovirus Types 2a and 2d.

Global Porcine Vaccines Market Scope

The porcine vaccines market is segmented on the basis of indication, technology, product type, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

• Swine Fever
• Porcine Parvovirus
• Aujeszky's Disease
• Swine Colibacillosis
• Porcine Pneumonia
• Porcine Pleropneumoniae
• Others

Technology

• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Other Vaccines

Product Type

• Improvac
• Suvaxyn
• Circumvent
• Circovac
• Others

Route of Administration

• Intravenous
• Intramuscular
• Others

End Use

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• Other

Porcine Vaccines Market Regional Analysis/Insights

The porcine vaccines market is analyzed and market size insights and trends are provided by indication, technology, product type, route of administration, end users and distribution channel as referenced above.

The countries covered in the porcine vaccines market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to grow during the forecast period of the porcine vaccines market because of the well-established veterinary healthcare infrastructure in the region. Also, the wide presence of top porcine production countries, such as China, and a large meat-consuming population, are boosting the market growth.

North America dominates the market in the forecast period due to increased infectious diseases within the region, such as classical swine fever (CSF). The increasing presence of a well-established veterinary healthcare infrastructure, growing demand for animal protein, and highly organized farming structure are anticipated to boost market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The porcine vaccines market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for porcine vaccines market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the porcine vaccines market. The data is available for historic period 2011-2021.

경쟁 환경 및 돼지 백신 시장 점유율 분석

돼지 백신 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 돼지 백신 시장과 관련된 회사의 초점에만 관련이 있습니다.

돼지 백신 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 베링거 인겔하임 인터내셔널 GmbH. (독일)
• FORMOSA BIOMEDICAL INC.(대만)
• 조에티스(미국)
• 데크라 파마슈티컬스 PLC(영국)
• Hester Biosciences Limited. (인도)
• 머크앤코(미국)
•  노바티스 AG(스위스)
• 엘란코(미국)
• Phibro Animal Health Corporation (미국)
• HIPRA, SA(스페인)
• Bimeda, Inc (아일랜드)
• 세바(프랑스)
• ARKO 연구소(미국)

SKU-52036